PDS BIOTECHNOLOGY CORPORATION
PDSBCIK 0001472091
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$34.28M
+16.1% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.74
+28.2% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$36.78M
Q1 May 2026
Cash
$21.66M
Q1 May 2026
Total Debt
$15M
Q1 May 2026
Shares Outstanding
55.82M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.